Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Healthcare Holding Schweiz buys stake in Alpin Orthodontics

Healthcare Holding Schweiz, a medtech and services firm backed by private equity firm KKA Partners and family office Winterberg Advisory, has acquired shares in Swiss orthodontic products and consumables provider Alpin Orthodontics AG. Founded in 1995, Alpin is the exclusive representative in Switzerland and Liechtenstein for several major international brands, including GC Orthodontics and Tiger […]
March 19, 2026

SHS Capital exits and reinvests in German speciality pharma AMW GmbH

Healthcare focused private equity firm SHS Capital has exited and reinvested in German speciality pharma company AMW GmbH, as part of a syndicate of investors including specialist investment firm Ren Life Sciences and global investment firm Juno Capital Partners.
March 19, 2026

EQT fully exits dermatology company Galderma

Swedish private equity firm EQT has fully exited Swiss pure-play dermatology company Galderma through a CHF 4.9 billion (~$6.21 billion) block trade. EQT and its co-investors, including sovereign wealth funds Abu Dhabi Investment Authority (ADIA) and GIC (Singapore), sold their remaining 14.3% stake (around 34 million shares). EQT VIII is expected to receive approximately CHF 1.3 billion (~$1.65 billion).
March 18, 2026

Simplified IT and sales processes key to accelerating AI adoption in imaging — DeepHeath’s Niccolo Stefani

US-based outpatient diagnostic imaging services provider RadNet has recently acquired French radiology AI company Gleamer in an all-cash transaction valued at €230 million (~$270 million). HBI spoke to Niccolo Stefani, Business Leader Population Health & Clinical AI, RadNet DeepHealth, about what this acquisition means for the AI platform and the overall adoption of AI in imaging.
March 18, 2026

Schön Klinik Group to exit the UK 

Schoen Klinik Group, Germany’s fourth-largest family-run hospital, is exiting the UK market, following a portfolio reconsideration. With this exit, Schoen Klinik will now focus primarily on its core market, Germany. 
March 18, 2026

Navigating the global pharma order in 2026 —in conversation with ING’s Stephen Farrelly and Diederik Stadig

Ahead of the HBI 2026 session ‘The new global pharma order: Trump, China and Europe's uncertain future’, HBI spoke to Stephen Farrelly, Managing Director, Global Lead Healthcare & Pharma at ING and Diederik Stadig, Senior Economist, Healthcare & Pharma at ING on what the future holds for pharma investment and strategy, from regulatory risks and European biopharma's structural challenges to the evolving role of CDMOs, CROs, and the role of private equity.
March 18, 2026

Interview: Nadine Hachach-Haram, Proximie 

Proximie is a UK-headquartered healthtech company that has built a platform aimed at improving the way surgery is done and the way operating rooms (ORs) function. In the first few years of the company’s existence, it was essentially a telehealth platform for surgeons, helping them collaborate, guide and educate one another across the world via a video connection. But since HBI last interviewed Proximie's CEO and founder Nadine Hachach-Haram in 2023, it’s been transformed into a super-high-tech platform that uses ambient data capture and AI to optimise OR workflows and improve surgery outcomes.
March 13, 2026

FREE BLOG What is “value” in healthcare and how will it be defined in the future?

By 2030, some forecasters see the healthcare landscape transforming from a reactive, acute-care model into a proactive, personalised, and data-driven ecosystem. This shift will be underpinned by the integration of advanced technologies like genomics, the Internet of Medical Things and of course AI. In this vision, healthcare will be reshaped by precision medicine, decentralised care, intelligent hospitals, and AI enabled diagnostics. 
March 12, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us